Saturna Capital Corp Astrazeneca PLC Transaction History

Saturna Capital Corp

$7.5 Billion
Q3 2024

A detailed history of Saturna Capital Corp transactions in Astrazeneca PLC stock. As of the latest transaction made, Saturna Capital Corp holds 1,674,852 shares of AZN stock, worth $110 Million. This represents 1.74% of its overall portfolio holdings.

Number of Shares

1,674,852

Previous 1,672,209 0.16%

Holding current value

$110 Million

Previous $130 Million 0.07%

% of portfolio

1.74%

Previous 1.75%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	BUY	$76.67 - $87.62 $202,638 - $231,579	2,643 Added 0.16%	1,674,852 $131 Million
Q2 2024 Jul 31, 2024	BUY	$66.81 - $80.83 $205,774 - $248,956	3,080 Added 0.18%	1,672,209 $130 Million
Q1 2024 May 13, 2024	BUY	$61.03 - $69.57 $24.1 Million - $27.5 Million	395,598 Added 31.06%	1,669,129 $113 Million
Q4 2023 Feb 06, 2024	BUY	$61.89 - $69.28 $12.3 Million - $13.8 Million	198,958 Added 18.52%	1,273,531 $85.8 Million
Q3 2023 Nov 14, 2023	SELL	$64.85 - $71.7 $45,394 - $50,190	-700 Reduced 0.07%	1,074,573 $72.8 Million
Q2 2023 Aug 04, 2023	BUY	$69.91 - $75.81 $375,416 - $407,099	5,370 Added 0.5%	1,075,273 $77 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $101,671 - $115,275	1,610 Added 0.15%	1,069,903 $74.3 Million
Q4 2022 Feb 09, 2023	BUY	$54.21 - $70.44 $1.37 Million - $1.78 Million	25,260 Added 2.42%	1,068,293 $72.4 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $13.2 Million - $33.9 Million	249,360 Added 31.42%	1,043,033 $57.2 Million
Q2 2022 Aug 12, 2022	BUY	$59.26 - $71.14 $47 Million - $56.5 Million	793,673 New	793,673 $52.4 Million
Q1 2019 May 15, 2019	SELL	$35.49 - $43.02 $212,940 - $258,120	-6,000 Closed	0 $0
Q2 2017 Aug 14, 2017	BUY	N/A	6,000	6,000 $205,000

Others Institutions Holding AZN

# of Institutions

1,359

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $203B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.

Account

Saturna Capital Corp Astrazeneca PLC Transaction History